Ammanamanchi S - Search Results

1

A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.

Kato A, Ng S, Thangasamy A, Han H, Zhou W, Raeppel S, Fallon M, Guha S, Ammanamanchi S. Kato A, et al. Among authors: ammanamanchi s. Mol Carcinog. 2021 Nov;60(11):734-745. doi: 10.1002/mc.23339. Epub 2021 Aug 4. Mol Carcinog. 2021. PMID: 34347914 Free PMC article.

2

Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells.

Thangasamy A, Rogge J, Ammanamanchi S. Thangasamy A, et al. Among authors: ammanamanchi s. J Biol Chem. 2008 Feb 29;283(9):5335-43. doi: 10.1074/jbc.M706957200. Epub 2007 Dec 28. J Biol Chem. 2008. PMID: 18165235 Free article.

3

Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells.

Zhao S, Ammanamanchi S, Brattain M, Cao L, Thangasamy A, Wang J, Freeman JW. Zhao S, et al. Among authors: ammanamanchi s. J Biol Chem. 2008 Apr 25;283(17):11293-301. doi: 10.1074/jbc.M800154200. Epub 2008 Feb 29. J Biol Chem. 2008. PMID: 18310076 Free PMC article.

4

Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.

Thangasamy A, Rogge J, Ammanamanchi S. Thangasamy A, et al. Among authors: ammanamanchi s. J Biol Chem. 2009 May 22;284(21):14001-10. doi: 10.1074/jbc.M809320200. Epub 2009 Mar 23. J Biol Chem. 2009. PMID: 19307182 Free PMC article.

5

Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion.

Thangasamy A, Rogge J, Krishnegowda NK, Freeman JW, Ammanamanchi S. Thangasamy A, et al. Among authors: ammanamanchi s. J Biol Chem. 2011 Sep 16;286(37):32115-22. doi: 10.1074/jbc.M111.245746. Epub 2011 Jul 28. J Biol Chem. 2011. PMID: 21799005 Free PMC article.

6

Urolithin A targets the AKT/WNK1 axis to induce autophagy and exert anti-tumor effects in cholangiocarcinoma.

Sahashi H, Kato A, Yoshida M, Hayashi K, Naitoh I, Hori Y, Natsume M, Jinno N, Kachi K, Asano G, Toyohara T, Kito Y, Ammanamanchi S, Kataoka H. Sahashi H, et al. Among authors: ammanamanchi s. Front Oncol. 2022 Sep 23;12:963314. doi: 10.3389/fonc.2022.963314. eCollection 2022. Front Oncol. 2022. PMID: 36212467 Free PMC article.

7

Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.

Narasimhan M, Ammanamanchi S. Narasimhan M, et al. Among authors: ammanamanchi s. Cancer Res. 2008 Jul 1;68(13):5185-92. doi: 10.1158/0008-5472.CAN-07-6883. Cancer Res. 2008. PMID: 18593918

8

Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.

Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D, Freeman JW. Venkatasubbarao K, et al. Among authors: ammanamanchi s. Cancer Res. 2001 Aug 15;61(16):6239-47. Cancer Res. 2001. PMID: 11507078

9

5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.

Ammanamanchi S, Brattain MG. Ammanamanchi S, et al. J Biol Chem. 2001 Aug 31;276(35):32854-9. doi: 10.1074/jbc.M103951200. Epub 2001 Jul 6. J Biol Chem. 2001. PMID: 11443124 Free article.

10

Sp3 is a transcriptional repressor of transforming growth factor-beta receptors.

Ammanamanchi S, Brattain MG. Ammanamanchi S, et al. J Biol Chem. 2001 Feb 2;276(5):3348-52. doi: 10.1074/jbc.M002462200. Epub 2000 Oct 10. J Biol Chem. 2001. PMID: 11027677 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters